Cleveland Clinic Cancer Advances
From Blood Sugar to Blood Cancer: Surprising Benefits of GLP-1s
01 May 2025
Description
Abhay Singh, MD, MPH, Director of the CHIP Clinic at Cleveland Clinic, joins the Cancer Advances Podcast to discuss a major new study exploring the link between GLP-1 receptor agonists and the risk of hematologic malignancies in patients with diabetes. Tune in to hear how GLP-1s, best known for managing diabetes and obesity, may hold promise for cancer prevention and what this could mean for future cardio-oncology care.
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster